Skip to main content

Cholangiocarcinoma

Cholangiocarcinoma

FGFR Inhibition in Cholangiocarcinoma: Overcoming Acquired Resistance

Cholangiocarcinoma

Targeted Therapies in Cholangiocarcinoma: Next-Generation Sequencing Is a Must

Cholangiocarcinoma

Using Tumor Organoid-Based Functional Analysis to Predict Drug Sensitivities in Patients with Cholangiocarcinoma

Cholangiocarcinoma

Improving Chemotherapy Combinations and Novel Treatments Are Needed in Advanced Biliary Tract Cancer

Cholangiocarcinoma

A Comprehensive Genomic Profiling Study Comparing Primary Tumor, Metastatic Tumor Tissue, and Liquid Biopsy in Patients with Intrahepatic CCA

Cholangiocarcinoma

PROOF Trial: A Multicenter, Open-Label Randomized, Phase 3 Trial of Infigratinib versus Gemcitabine plus Cisplatin in Patients with Advanced CCA with FGFR2 Gene Rearrangements

Cholangiocarcinoma

The Worldwide Incidence of Biliary Tract Cancer

Cholangiocarcinoma

Early Molecular Testing for Patients with CCA Crucial to Inform Treatment Choices

Cholangiocarcinoma

PFS to Systemic Therapy in Patients with CCA with FGFR2 Fusions or Rearrangements

Cholangiocarcinoma

Therapeutic Targeting of Extracellular FGFR2 Activating Deletions in Intrahepatic CCA

4
5
6
7
8
9
10

Page 7 of 10
Results 61 - 70 of 99